Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q3 2025 Earnings

6AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-13.08

-9.23

-5.38

-1.53

Details

Expected EPS

-2.363333

Actual EPS

-1.53

Surprise EPS

0.83

Surprise Percent

+35.26%

Description

Aligos Therapeutics (ALGS) has reported earnings of -1.53 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.